Maxivision Super Speciality Eye Hospitals Revenue and Competitors

Begumpet,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Maxivision Super Speciality Eye Hospitals's estimated annual revenue is currently $22M per year.(i)
  • Maxivision Super Speciality Eye Hospitals's estimated revenue per employee is $154,000

Employee Data

  • Maxivision Super Speciality Eye Hospitals has 143 Employees.(i)
  • Maxivision Super Speciality Eye Hospitals grew their employee count by 17% last year.

Maxivision Super Speciality Eye Hospitals's People

NameTitleEmail/Phone
1
Sr accounts executiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.1M1015%N/AN/A
#2
$1.6M19-71%N/AN/A
#3
$212.8M10635%$65MN/A
#4
$6.8M548%N/AN/A
#5
$12.9M922%$23.1MN/A
#6
$1M12N/AN/AN/A
#7
$106.5M599-17%$2.3MN/A
#8
$35.6M2316%N/AN/A
#9
$38.3M2495%N/AN/A
#10
$45M299-4%$102.6MN/A
Add Company

What Is Maxivision Super Speciality Eye Hospitals?

Maxivision Super Specialty Eye Hospitals is one of the leading eye care facilities in India today. Maxivision takes pride in being India's first LASIK centre in the year 1996. We have come a long way since to be recognized as one of the most trusted brands in eye care offering a complete spectrum of vision care treatments. So far we have provided outpatient eye care to more than 24 lakh people from all over the globe. In addition to this, almost three lakh patients have undergone eye surgeries at the various Maxivision branches located across six Indian cities.

keywords:N/A

N/A

Total Funding

143

Number of Employees

$22M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Maxivision Super Speciality Eye Hospitals News

2022-04-06 - Use of cow dung may be cause of black fungus: American Society of Microbiology research

... black fungus at the Mucormycosis ward of a government hospital in Hyderabad. ... Maxivision Super Speciality Eye Hospitals, Tiruchy.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$245.9M5969%N/A